- Home
- VIR vs CSTL Comparison
VIR vs CSTL Comparison
Compare VIR & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- CSTL
- Stock Information
- Founded
- VIR 2016
- CSTL 2007
- Country
- VIR United States
- CSTL United States
- Employees
- VIR N/A
- CSTL N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- CSTL Medical Specialities
- Sector
- VIR Health Care
- CSTL Health Care
- Exchange
- VIR Nasdaq
- CSTL Nasdaq
- Market Cap
- VIR 1.0B
- CSTL 848.1M
- IPO Year
- VIR 2019
- CSTL 2019
- Fundamental
- Price
- VIR $7.47
- CSTL $26.83
- Analyst Decision
- VIR Buy
- CSTL Strong Buy
- Analyst Count
- VIR 5
- CSTL 6
- Target Price
- VIR $36.40
- CSTL $39.67
- AVG Volume (30 Days)
- VIR 1.4M
- CSTL 295.7K
- Earning Date
- VIR 02-20-2025
- CSTL 11-04-2024
- Dividend Yield
- VIR N/A
- CSTL N/A
- EPS Growth
- VIR N/A
- CSTL N/A
- EPS
- VIR N/A
- CSTL 0.21
- Revenue
- VIR $78,618,000.00
- CSTL $311,878,000.00
- Revenue This Year
- VIR N/A
- CSTL $51.36
- Revenue Next Year
- VIR N/A
- CSTL N/A
- P/E Ratio
- VIR N/A
- CSTL $127.54
- Revenue Growth
- VIR N/A
- CSTL 62.43
- 52 Week Low
- VIR $6.56
- CSTL $16.97
- 52 Week High
- VIR $13.09
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- VIR 45.87
- CSTL 35.52
- Support Level
- VIR $7.15
- CSTL $26.99
- Resistance Level
- VIR $7.56
- CSTL $28.08
- Average True Range (ATR)
- VIR 0.40
- CSTL 1.48
- MACD
- VIR -0.02
- CSTL -0.18
- Stochastic Oscillator
- VIR 24.79
- CSTL 8.45
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.